Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations
- DOI
- 10.3389/fphar.2026.1868595
- Published
- 2026-09-03
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1868595,
title = {Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations},
author = {Alberto Orta and Miguel Angel Hidalgo-Leon and Carlos Lacalle-Gonzalez and Miriam M. Rodriguez de Lope and Lara Sanz-Criado and Jesus Garcia-Foncillas and Javier Martinez-Useros},
year = {2026},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2026.1868595},
url = {https://doi.org/10.3389/fphar.2026.1868595}
}RIS
TY - JOUR TI - Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations AU - Alberto Orta AU - Miguel Angel Hidalgo-Leon AU - Carlos Lacalle-Gonzalez AU - Miriam M. Rodriguez de Lope AU - Lara Sanz-Criado AU - Jesus Garcia-Foncillas AU - Javier Martinez-Useros PY - 2026 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2026.1868595 UR - https://doi.org/10.3389/fphar.2026.1868595 ER -
APA
Orta, A., Hidalgo-Leon, M. A., Lacalle-Gonzalez, C., Lope, M. M. R. D., Sanz-Criado, L., Garcia-Foncillas, J., & Martinez-Useros, J. (2026). Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1868595
Source records
- crossref · retrieved 2026-09-26T15:35:30.515Z